🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will enroll patients who received neoadjuvant therapy for TNBC p...
Status
Active Not Recruiting
Location
Korea University, Guro hospital
Start Date
2019-01-15
Trial ID
NCT03756298
Treatments Being Tested
This is an open-label, multicenter, Phase 1a study to evaluate the safety, ...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2021-09-07
Trial ID
NCT04975958
Treatments Being Tested
This is an open-label, multicenter, randomized phase II trial to evaluate t...
Status
Unknown
Location
UZLeuven
Start Date
2017-08-30
Trial ID
NCT03340376
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the t...
Status
Not Yet Recruiting
Location
Fundeni Clinical Institute
Start Date
2025-04
Trial ID
NCT06903663
This study aims to find out: 1. The tolerability of Cabotamig (ARB202) in ...
Status
Completed
Location
Southern Oncology Clinical Research Unit
Start Date
2022-05-30
Trial ID
NCT05411133
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of atezoliz...
Status
Completed
Location
Moores Cancer Center at UC San Diego Health
Start Date
2021-03-02
Trial ID
NCT04665843
Treatments Being Tested
This randomized phase III trial studies how well paclitaxel, trastuzumab, a...
Status
Terminated
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-04-05
Trial ID
NCT03199885
This is a phase II clinical trial aimed at evaluating the efficacy of PD-L1...
Status
Completed
Location
AdventHealth Orlando
Start Date
2017-07-18
Trial ID
NCT03014648
Treatments Being Tested
This study will test whether valemetostat in combination with atezolizumab ...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-01-29
Trial ID
NCT06807632
Treatments Being Tested
This phase II trial tests how well atezolizumab works in treating patients ...
Status
Recruiting
Location
Emory University Hospital Midtown
Start Date
2023-10-27
Trial ID
NCT06254911